In this first of four videos, Steven J. Weiss, MD, Chief, Cardiac Surgery, Chester County Hospital, discusses the balance of risk vs. benefit in the treatment of patients with mitral regurgitation or aortic stenosis, and considers mortality vs. survival for patients receiving surgery and those not operated upon for these conditions.
To view other parts of this program:
Part 2: Assessing the Patient for Mitral Valve Disease
Part 3:Assessing the Patient for Aortic Valve Disease
Part 4: TAVR for Aortic Stenosis: Case Report
- Dr. Weiss’s Profile
- Clinical Briefing: Transcatheter Aortic Valve Replacement for Aortic Stenosis in Inoperable Patients
- Case Study: An 88-year-old man with a heavily calcified aortic valve and progressive heart failure (LVEF 30%) is referred for a TAVR procedure at Penn Medicine.